openPR Logo
Press release

Ocular Drug Delivery Market (2020-2027) : Inclusive Study of the Growth Factors

03-13-2020 05:53 PM CET | Health & Medicine

Press release from: Allied Market Research

Ocular Drug Delivery Market

Ocular Drug Delivery Market

According to a new report published by Allied Market Research, titled, " Ocular Drug Delivery Market by Technology (Topical, Iontophoresis, Ocular Insert [Erodible and Non-Erodible], Intraocular Implants [Biodegradable and Non-Biodegradable], In Situ Gel & Punctal Plugs, and Others), Formulation Type (Liposomes & Nanoparticles, Solution, Emulsion, Suspension, and Ointment), by Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and by End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, and Homecare Settings) - Global Opportunity Analysis and Industry Forecast, 2020-2027".

The Global market size of Ocular Drug Delivery market is $XX million in 2020 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with a CAGR of XX% from 2020 to 2027.

Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/3646

Comprehensive competitive analysis and profiles of major market players such as Valeant Pharmaceuticals International, Inc., Taiwan Liposome Company, Ltd., Ocular Therapeutix, Inc., Graybug Vision Inc., EyeGate Pharma, Clearside Biomedical, Inc., Alimera Sciences, EyeGate Pharma, Envisia Therapeutics, and Allergan, Plc. have also been provided in this report.

Key Benefits
o The study provides an in-depth analysis of the market, with current trends and future estimations to elucidate investment pockets.
o Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
o The report provides a quantitative analysis to help stakeholders to capitalize on prevailing market opportunities.
o Extensive analysis of different segments helps understand various products of the market.
o Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/3646

Ocular Drug Delivery Market Key Segments:
By Technology
o Topical
o Iontophoresis
o Ocular Insert
o Erodible
o Non-Erodible
o Intraocular Implants
o Biodegradable
o Non-Biodegradable
o In Situ Gel & Punctal Plugs
o Others

By Formulation Type
o Liposomes & Nanoparticles
o Solution
o Emulsion
o Suspension
o Ointment

By Disease Type
o Glaucoma
o Diabetic Retinopathy
o Dry Eye Syndrome
o Macular Degeneration
o Cataract
o Diabetic Macular Edema
o Others

By End Users
o Hospitals
o Ophthalmic Clinics
o Ambulatory Surgical Centers
o Homecare Settings

By Region
o North America
o U.S.
o Canada
o Mexico
o Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
o Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Taiwan
o Rest of Asia-Pacific
o LAMEA
o Brazil
o Turkey
o Saudi Arabia
o South Africa
o Rest of LAMEA

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

help@alliedmarketresearch.com

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ocular Drug Delivery Market (2020-2027) : Inclusive Study of the Growth Factors here

News-ID: 1967057 • Views: 230

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Ocular

Surge in demand for advanced ocular drug delivery approaches
The major factor that contributes to the growth of the ocular drug delivery market includes increase in number of people suffering from eye disorders such as glaucoma, diabetic retinopathy, dry eye syndrome, and others. Moreover, rise in geriatric population, surge in demand for targeted ocular drug delivery techniques, and increase in the number of regulatory approvals for these techniques drive the market growth. However, higher cost of drug delivery devices and
Ocular Hypertension - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H2 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor
Ocular Hypertension-Pipeline Review H2 2017
ReportsWeb.com has announced the addition of the “Ocular Hypertension-Pipeline Review H2 2017” this report provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor does not flow through the trabecular meshwork properly, fluid pressure in the eye builds up, causing ocular hypertension. There are no symptoms with ocular hypertension. Risk factors include
Ocular Implants Market Competitive Dynamics & Global Outlook 2024
Global Ocular Implants Market: Overview Ocular implants are used for the medical surgeries that deal with the replacement of the injured eye or to increase the sharpness of the vision. Different types of implants are available in the market which can be used for the treatment of various eye disorders. The implants such as implants for glaucoma surgery, intraocular lenses, corneal implants all these are used to treat the injured or
Ocular Hypertension - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H1 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous
Research Announces: Global Ocular Pain Market
MarketResearchReports.Biz presents this most up-to-date research on "Ocular Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" DelveInsights Report, Ocular Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Ocular Pain Report is to understand the market and pipeline status of the drugs around the